The company also has a subscribed and paid capital of RON453 million, according to the same sources.

In December 2013, GSK said it expected to select a buyer for its medicines production line in Brasov, central Romania, by the end of the first quarter of 2014 but would start shutdown procedures in 2015 unless it manages to sell it.

In 1996 GSK bought 65% in Romania’s Europharm, a company then owned by businessman Mihai Miron and which came with a medicine production unit in Brasov. In 2003 GSK bought the remaining 35% stake in Europharm.

According to market research company Cegedim, at the end of September, GSK ranked 6th on the Romanian pharmaceutical market, with a 4.8% market share.

(EUR1=RON4.5261)